China Shineway Pharmaceutical Group Limited (C1S) — Financial Flexibility Index
China Shineway Pharmaceutical Group Limited (C1S) has a Financial Flexibility Index of 0.08x as of June 2023. Free cash flow of €185.26 Million (operating CF €160.69 Million minus capex €24.57 Million) represents 0% of total liabilities (€2.26 Billion). Also explore C1S year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
China Shineway Pharmaceutical Group Limited Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for China Shineway Pharmaceutical Group Limited across 13 annual periods. Check China Shineway Pharmaceutical Group Limi strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for China Shineway Pharmaceutical Group Limited (2013–2025)
Year-by-year free cash flow to debt coverage for China Shineway Pharmaceutical Group Limited. For the full company profile including market capitalisation, see China Shineway Pharmaceutical Group Limi (C1S) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | €1.37 Billion | €1.17 Billion | €2.72 Billion | ▲ +17.7% |
| 2024 | 0.43x | €1.10 Billion | €963.13 Million | €2.57 Billion | ▲ +1.0% |
| 2023 | 0.42x | €1.08 Billion | €932.63 Million | €2.54 Billion | ▼ -36.7% |
| 2022 | 0.67x | €1.24 Billion | €1.11 Billion | €1.85 Billion | ▲ +9.5% |
| 2021 | 0.61x | €796.78 Million | €703.15 Million | €1.30 Billion | ▲ +23.2% |
| 2020 | 0.50x | €704.59 Million | €638.57 Million | €1.42 Billion | ▲ +47.3% |
| 2019 | 0.34x | €456.40 Million | €368.00 Million | €1.35 Billion | ▼ -50.7% |
| 2018 | 0.68x | €659.92 Million | €532.59 Million | €966.01 Million | ▼ -1.0% |
| 2017 | 0.69x | €582.47 Million | €490.65 Million | €844.16 Million | ▼ -31.1% |
| 2016 | 1.00x | €840.32 Million | €733.53 Million | €838.59 Million | ▲ +0.9% |
| 2015 | 0.99x | €851.26 Million | €744.71 Million | €857.13 Million | ▲ +14.8% |
| 2014 | 0.86x | €877.34 Million | €773.16 Million | €1.01 Billion | ▲ +44.8% |
| 2013 | 0.60x | €781.77 Million | €519.89 Million | €1.31 Billion | — |